Breast-Specific Gamma Imaging Effective For All Breast Densities
Breast-specific gamma imaging detects breast cancer in both dense and nondense breast tissue.
Breast-specific gamma imaging (BSGI) is highly sensitive for detecting breast cancer in women with either dense or nondense breasts, according to a study published in the American Journal of Roentgenology.
Researchers from The George Washington University, in Washington, D.C., undertook a retrospective study of 341 women who had been diagnosed with breast cancer from January 2004 to August 2009 and who had undergone BSGI before surgical excision.
Women with predominantly fatty replaced (BI-RADS density 1) or scattered fibroglandular tissue (BI-RADS density 2) breasts were classified as nondense, and those with heterogeneously dense (BI-RADS density 3) or extremely dense tissue (BIRADS density 4) were classified as dense.
The results showed that overall sensitivity of BSGI for breast cancer detection was 95.4 percent. Positive BSGI examinations were present in 136 of 142 nondense breast cancers and 195 of 205 dense breast cancers, for sensitivities of 95.8 percent and 95.1 percent, respectively. There was no significant difference in BSGI breast cancer detection and parenchymal breast density.
“BSGI has high sensitivities for the detection of breast cancer in women with dense and nondense breasts and is an effective adjunct imaging modality in women with both dense and nondense breasts,” the authors concluded.
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
The Reading Room Podcast: Current and Emerging Insights on Abbreviated Breast MRI, Part 2
July 23rd 2025In the second part of a multi-part podcast episode, Stamatia Destounis, MD, Emily Conant, MD and Habib Rahbar, MD, discuss key sequences for abbreviated breast MRI and how it stacks up to other breast cancer screening modalities.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
Can Contrast-Enhanced Mammography be a Viable Screening Alternative to Breast MRI?
June 17th 2025While the addition of contrast-enhanced mammography (CEM) to digital breast tomosynthesis (DBT) led to over a 13 percent increase in false positive cases, researchers also noted over double the cancer yield per 1,000 women in comparison to DBT alone.
